GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the unliganded bromodomain of human BRD9

Analyse Crystal structure of the unliganded bromodomain of human BRD9 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6UZF
Type
protein
Length
104 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bromodomain-containing protein 9
UniProt
Q9H8M2
Ligands
SO4
Pockets
1 · best druggability 0.43

Structure

x-ray diffraction · 1 distinct chain · 61% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABromodomain-containing protein 9protein10461% helix, 0% strandQ9H8M2

Ligands and binding sites

  • SO4 · Sulfate ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1820.430.7918DMS

Compared structures

  • 6UZF · Crystal structure of the unliganded bromodomain of human BRD9 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H8M2 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 9 (Q9H8M2) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.